Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
16.25 USD | +1.56% | +16.24% | +55.65% |
May. 08 | Sector Update: Health Care Stocks Slipping Wednesday Afternoon | MT |
May. 08 | Teva Pharmaceutical Shares Rise After Reporting Higher Q1 Earnings, Revenue; 2024 Guidance Reaffirmed | MT |
Financials (USD)
Sales 2024 * | 15.92B | Sales 2025 * | 16.49B | Capitalization | 18.41B |
---|---|---|---|---|---|
Net income 2024 * | 820M | Net income 2025 * | 1.39B | EV / Sales 2024 * | 2.09 x |
Net Debt 2024 * | 14.93B | Net Debt 2025 * | 12.41B | EV / Sales 2025 * | 1.87 x |
P/E ratio 2024 * |
17.3
x | P/E ratio 2025 * |
12
x | Employees | 35,737 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 89.71% |
Latest transcript on Teva Pharmaceutical Industries Limited
1 day | +1.56% | ||
1 week | +16.24% | ||
Current month | +15.66% | ||
1 month | +17.33% | ||
3 months | +35.30% | ||
6 months | +87.21% | ||
Current year | +55.65% |
Managers | Title | Age | Since |
---|---|---|---|
Richard Francis
CEO | Chief Executive Officer | 55 | 22-12-31 |
Eli Kalif
DFI | Director of Finance/CFO | 51 | 19-12-21 |
Eric Hughes
CTO | Chief Tech/Sci/R&D Officer | - | 22-07-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Gerald Lieberman
BRD | Director/Board Member | 77 | 15-08-31 |
Janet Vergis
BRD | Director/Board Member | 59 | 20-06-08 |
Sol Barer
CHM | Chairman | 76 | 14-12-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
6.38% | 13 M€ | -.--% | ||
0.27% | 0 M€ | +7.69% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-10 | 16.25 | +1.56% | 13,820,259 |
24-05-09 | 16 | +1.65% | 16,780,250 |
24-05-08 | 15.74 | +12.83% | 38,497,848 |
24-05-07 | 13.95 | -0.78% | 13,631,979 |
24-05-06 | 14.06 | +0.57% | 9,146,663 |
Delayed Quote Nyse, May 10, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+55.65% | 18.41B | |
+30.38% | 684B | |
+26.51% | 568B | |
-4.36% | 361B | |
+19.30% | 329B | |
+3.73% | 284B | |
+16.70% | 240B | |
+8.78% | 208B | |
-7.93% | 200B | |
+7.68% | 166B |
- Stock Market
- Equities
- TEVA Stock